CariGenetics Earns Award At Forum In London

The CariGenetics team represented Bermuda at MedTech Investing [MTI] Europe Forum in London, earning the ‘Best in Show’ award.

A spokesperson said, “The CariGenetics team proudly represented Bermuda on the global stage at the 34th MedTech Investing [MTI] Europe Forum in London held by Campden Wealth last week from 2-3 July 2024. CariGenetics not only presented at the forum but also won the highly competitive pitch competition, earning the ‘Best in Show’ award, putting the Caribbean on the map for innovative biotechnology.

“The CariGenetics delegation included:

• Dr Carika Weldon, Founder and CEO, CariGenetics

• Dr Jacqueline Hall, Head of Real-World Data, CariGenetics

• Mark Bailey, Head of Fundraising and Partnerships, CariGenetics

• Kevin Richards, Managing Director of Bermuda Asset Management and CariGenetics Business Development Advisory Board

“This event provided the opportunity to network with over 50 potential investors, alongside 25 other companies, further elevating the profile of CariGenetics on an international level.

“The MTI Europe Forum, now in its 34th edition, relocated from Lausanne to London, supported by a vibrant investment community. The event featured 26 medical technology companies pitching investment opportunities to an audience of 100 delegates, including family offices, private wealth holders, venture capitalists, corporations, and angel investors. The forum programme addressed major challenges and opportunities in healthcare, life sciences, AI, and digital health investment.”

Dr Carika Weldon showcased CariGenetics as being The Caribbean Real World Evidence and Engagement Platform. ”

Our platform is pivotal in advancing healthcare research, expanding therapeutic access and improving patient care in the Caribbean. Winning this competition highlights the importance of our work whilst solidifying our company as a viable investment opportunity from a global lens,” stated Dr Weldon.

“The standard of technology and innovation on show at the 34thMedTech Investing Forum in London last week was breathtaking and augmented by the compelling plenary sessions from the NHS and Industry. CariGenetics were a worthy winner of the ‘Best in Show’ award and highlighted the cutting- edge innovation that is currently being developed in Bermuda,” said Kevin Grant, Executive Director, Campden Wealth.

“We are thrilled with the opportunity to connect with such a diverse and influential group of investors and innovators. It is a significant step towards securing the investment, partnerships, and collaborations needed to ensure the success of our research initiatives,” said Mark Bailey, Head of Fundraising & Partnerships.

Kevin Richards, Managing Director of Bermuda Asset Management, and member of the CariGenetics Business Development Advisory Board added, “Representing Bermuda at such a prestigious event underscores our commitment to bringing world-class research and innovation to the Caribbean. Our participation and success at the MTI Europe Forum demonstrate our capability and vision to make a global impact.”

The spokesperson said, “The team’s success at the MTI Europe Forum is a testament to their dedication and the critical importance of their work in advancing healthcare. CariGenetics is actively seeking investment, partnerships, and collaborations to further their vital work. Anyone interested in joining the journey should email: carika@carigenetics.com.”

#CariGenetics #GoodNews

Category: All, News, technology